The Outcomes of Colonic Stenting as a Bridge to Surgery for Left-Sided Malignant Colonic Obstruction: A Single-Center Retrospective Cohort Study
This single-center retrospective study of 20 patients demonstrates that colonic stenting as a bridge to surgery for left-sided malignant colonic obstruction achieves high technical success, facilitates stoma-free primary anastomosis and minimally invasive resection, and yields favorable short-term surgical and oncologic outcomes, though larger prospective studies are needed to confirm these findings.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a tumor grows inside the colon, the large intestine that processes waste, it can eventually block the passage of stool. This blockage is a medical emergency that turns a manageable condition into a life-threatening crisis. Without intervention, the pressure builds until the bowel wall weakens, risking a rupture that spills waste into the abdomen. In the past, the standard response to such a blockage on the left side of the colon was immediate, high-risk surgery. Surgeons would often have to remove the blocked section and create a temporary or permanent opening in the abdomen, called a stoma, to let waste exit the body while the area healed. This approach saved lives but often left patients with a bag to wear and a lower chance of having their bowel reconnected later.
In recent years, doctors have developed a different path for selected patients. Before cutting into the abdomen, they can insert a self-expanding metal mesh tube, known as a stent, through a camera passed down the throat and into the colon. This tube pushes against the tumor from the inside, opening the blockage and allowing stool to pass again. This procedure converts a chaotic emergency into a planned, elective surgery. The patient can recover from the blockage, receive better preoperative care, and undergo a more precise operation later. The critical question for medical teams is whether this two-step process is safe and effective enough to replace the immediate, one-step emergency surgery, particularly regarding the ability to reconnect the bowel without a stoma and to avoid long-term cancer risks.
Researchers at King Fahad Medical City in Riyadh, Saudi Arabia, set out to examine how this "bridge to surgery" approach worked in their own hospital. They looked back at the records of twenty adults who had non-metastatic cancer blocking the left side of their colon between 2013 and 2025. These patients were not suffering from cancer that had spread to other organs, and their goal was curative treatment. The team focused on the entire journey: the initial placement of the stent, the time spent waiting for surgery, the operation itself, and the recovery period. They wanted to see if the stent successfully opened the bowel, if it allowed surgeons to perform less invasive operations, and if the patients remained free of major complications or cancer recurrence in the months following treatment.
The results of this review showed a high level of success for this specific group of patients. In every single one of the twenty cases, the stent was successfully placed and immediately relieved the blockage, allowing the colon to function again. This success enabled the medical team to delay the surgery by a median of fifteen and a half days, giving patients time to stabilize. When the operations finally took place, the surgeons were able to reconnect the bowel without creating a stoma in nineteen out of the twenty patients. Furthermore, the majority of these surgeries were performed using minimally invasive techniques, such as laparoscopy or robotics, which involve small incisions rather than one large cut. Only one patient required a stoma, and only one patient needed a conversion from a minimally invasive approach to a traditional open surgery.
Safety outcomes were also encouraging. While some patients experienced minor issues after their operations, which is common in any major surgery, only one patient suffered a major complication, and no one died within thirty days of the procedure. There were no instances of the stent moving out of place, and only one patient experienced a perforation, or a small hole, caused by the stent itself. When the removed tissue was examined under a microscope, all twenty patients had their tumors completely removed with clear edges, and the surgeons collected a sufficient number of lymph nodes to check for the spread of cancer. Most patients went on to receive standard chemotherapy, and over a follow-up period averaging nearly two years, no one showed signs of the cancer returning.
The study suggests that for carefully selected patients with a blocked colon caused by cancer, placing a stent before surgery is a viable and effective strategy. It allows the bowel to be cleared and the patient to be optimized before the operation, leading to a high rate of successful bowel reconnection without a stoma and a high rate of minimally invasive surgery. The researchers noted that these positive results likely depend on the skill of the medical team and the careful selection of patients who do not have cancer that has spread elsewhere. While the study was limited to a small group of twenty people at a single center, the findings provide strong evidence that this approach can turn a dangerous emergency into a manageable, planned procedure with favorable short-term outcomes. The authors conclude that larger studies are needed to confirm these results across different hospitals and to track patients over longer periods, but for now, the data supports the use of stenting as a bridge to surgery in experienced centers.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.